Alexandra Kautzky-Willer is an expert in Endocrinology at Vienna General Hospital (Austria). As of October 2026, ScienceLeadR ranks Alexandra Kautzky-Willer in the top 1% of experts worldwide for Glucose Metabolism Disorders, Diabetes Mellitus and Diabetes, Gestational. Alexandra Kautzky-Willer has authored 653 publications, the most recent in 2026, and is an investigator in 41 clinical trials, 4 of them ongoing. SLR score: 2,354 (community average: 125). How the SLR is computed.

LeadR Profile

Alexandra Kautzky-Willer Vienna General Hospital Austria
2 354 ScienceLeadR Reputation 2354
Network Map

Endocrinology

Subspecialties: Cardiology - Nutrition - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026

Source: PubMed

Medical University of Vienna

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 653

Citations

Citations: 26 135 1st author: 58 Last author: 140 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Sex and gender differences belong in treatment guidelines.
PMID 42778765 — molecular biology, sex characteristics, sex, therapeutics, sex differences
Nat Med Top journal20260
Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial.
PMID 42747817 — glucagon-like peptide 1, quality of life, safety, cardiovascular diseases, frailty, semaglutide
JAMA Cardiol20260
Maternal and Neonatal Complications in Pregnant Women With Polyendocrine Metabolic Ovarian Syndrome: A Nested Prospective Cohort Study.
PMID 42747940 — diabetes mellitus, pregnant women, diabetes, gestational, pregnancy, parturition, ovary, cohort studies
Diabetes Care20260
Sex Differences in Endocrine Health: Insights from the EUWIN Community.
PMID 42647751 — diabetes mellitus, thyroid gland, hormones, sex characteristics, sex, endocrine system diseases, sex differences
Eur J Endocrinol20260
Association Between Relative Cord Hyperleptinemia and Offspring Outcomes in Pregnant Women With Overweight or Obesity.
PMID 42629609 — diabetes mellitus, pregnant women, diabetes, gestational, pregnancy, parturition, leptin, obesity, overweight, infant
Pediatr Obes20260

Clinical Studies 41

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 7 Study Chair: 1 Study Director: 1

By phase:

Phase 3 16
N/A 14
Phase 4 6
Phase 2 3
Phase 1 1
Phase 2/Phase 3 1

By status:

Completed 22
Unknown 10
Recruiting 7
Active not recruiting 1
Terminated 1

By type:

Interventional 33
Observational 8

By Monocentric/Multicentric:

monocentric 19
multicentric2to4 1
multicentric5to9 2
multicentricup10 19

Main Topics

Cohort/Consortium Investigators 7

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME CV)
2024-516652-18-00 — cardiovascular diseases, obesity, therapeutics, overweight
Phase 3Recruiting2025
The relationship of cholesterol lowering drugs with steroid HORMONEs bile acids muscle morphology vitamin D the immune system and related diseases such as depression and osteoporosis
2024-516967-10-00 — depression, vitamin d, bile, hyperlipidemias, muscles, vitamins, pharmaceutical preparations, hormones, cholesterol, osteoporosis, immune system, steroids
Phase 4Recruiting2024
Gender Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function Heart Liver and Pancreatic Fat Content
NCT06291675 — pilot projects, research design, pilots, glucose tolerance test, insulin, blood, heart, body composition, prescriptions, liver, hormones, gender dysphoria, research, therapeutics, lipids, men, women
N/ARecruiting2023
Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight Obese Men With T2DM or Prediabetes and Hypogonadism
NCT03851627 — diabetes mellitus, hypogonadism, insulin, eunuchism, non-alcoholic fatty liver disease, glucose intolerance, liver, solutions, testosterone, prediabetic state, obesity, methyltestosterone, therapeutics, overweight, fatty liver, diabetes mellitus, type 2, lipids, male, men
Phase 4Recruiting2022

LeadR Networks

Main global connection map